2 ms·
I'm always skeptical simple solutions proposed to solve complex problems. Unintended consequences or unanticipated roadblocks are often an issue. In this case,
by ineedasername 7y ago
I'm always skeptical simple solutions proposed to solve complex problems. Unintended consequences or unanticipated roadblocks are often an issue.
In this case, the author might under estimate the logistics involved in getting this done. At a minimum, the author does not adequately address the logistical challenges of this endeavor in the context of already challenging testing environments. The "quick & cheap" aspect of this is therefore a claim without support.
It might be a promising line of endeavor, and we should pursue multiple parallel initiatives, but the resources needed to pursue this are highly correlated with the resources needed to perform many of the other initiatives that are also promising. There is a bottleneck. Why should this take precedence over other already promising lines of inquiry?
- the-pigeon 7y agoI don't think this is a very simple solution at all. It's really just a different vaccine approach and this isn't the first person to suggest it. It's been talked about online since February if not before. Not to say I don't think it's a viable idea and I do think it needs more visibility. As the author states this has worked for other diseases.
- ineedasername 7y agoThe author proposes it as "quick & cheap" and leaves out nearly all logistical considerations. To my thinking, that is an overly-simple proposal.
- danieltillett 7y agoSomething can be quick and cheap without being easy. The proposal is far from easy. The post leaves out a lot of technical details that the average non-scientist doesn’t need to know.